FDA approves new immunoglobulin
FDA Approves Mavyret for Treatment of Acute HCV Infection
The therapy is the first and only oral direct acting antiviral approved by the FDA for HCV infection.
The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
Healthy Diet Provides Health Benefits, Even Without Weight Loss
Investigators find that patients with moderate weight loss or those who were weight resistant still had improvement in cardiometabolic health.
Scripted for Her: Addressing Preconception Health Through MTM
In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.
First-in-Class Oral Therapy Is Approved for Uncomplicated Urinary Tract Infection
This novel mechanism of action provides an alternative therapy for patients with recurrence or those who may not tolerate current first-line therapies.
Direct-to-Consumer Pharmacies: Why Skipping the Counter Puts Patients at Risk
Direct-to-consumer drug sales may undermine patient care and threaten independent pharmacies by reducing access to personalized, comprehensive medication management.
